Why GS-441524 FIP Treatment Fails: The Real Causes and What to Do About Them

GS-441524 achieves a 92% success rate for FIP treatment when administered at the correct dose for the full 84-day protocol, as established by the Pedersen et al. 2019 UC Davis trial (J Feline Med Surg). The cats that fall outside that 92% are not random failures — they are almost always traceable to specific, identifiable causes.

Understanding those causes is important for two reasons. First, most of them are preventable — knowing what causes failure allows you to avoid it. Second, when treatment is not working as expected, identifying the cause is the first step toward correcting it. This guide covers every documented cause of GS-441524 treatment failure, from most to least common, with what to do about each.

Cause 1: Treatment Started Too Late

GS-441524 suppresses viral replication. It cannot reverse damage that has already occurred. A cat with irreversible organ failure — kidneys that have lost functional capacity, liver replaced by granulomatous tissue, neural tissue destroyed by neurological FIP — may not recover even with correct treatment, because the drug cannot restore what the virus has already destroyed.

Late-stage FIP is not untreatable — many late-stage cats do achieve full remission with GS-441524 at the correct dose. But the proportion of cats that recover decreases as the degree of irreversible organ damage increases. The earlier treatment starts, the less damage has accumulated, and the more the drug has to work with.

What to do: If your cat has been diagnosed with FIP, start treatment as soon as possible — ideally within 24 to 48 hours of diagnosis. Do not wait for additional confirmatory tests if the clinical picture is clear. Read our guide on why every day counts and contact us to start immediately.

Cause 2: Stopping Treatment Early

This is the most common cause of FIP relapse. A cat that appears completely well at day 60 or 70 has not cleared the infection — the virus is suppressed, not eliminated. Stopping treatment before day 84 leaves residual viral replication occurring under sub-therapeutic conditions. The virus, no longer fully suppressed, resumes replication. Clinical signs return, typically within 2 to 8 weeks of stopping treatment.

The 84-day protocol duration is not arbitrary. It is the minimum duration required to suppress replication long enough for the immune system to complete the clearance process.

What to do: Complete all 84 days regardless of how well the cat appears. Set a calendar reminder for day 84. Do not stop early because the cat looks cured — clinical improvement is not viral clearance. Read our complete FIP relapse guide.

Cause 3: Under-Dosing

GS-441524 is dosed by body weight and FIP form. The correct doses:

  • Wet FIP: 6 mg/kg daily
  • Dry FIP: 8 mg/kg daily
  • Neurological FIP: 10 mg/kg daily
  • Ocular FIP: 10 mg/kg daily

Use our dosage calculator to verify the correct amount. Under-dosing is particularly common in two situations:

  • Dose not recalculated as the cat gains weight. A cat that weighed 3 kg at the start of treatment and weighs 4 kg at week 6 needs a 33% higher dose. Recalculate the dose every 2 to 3 weeks throughout the 84-day protocol.
  • Incorrect form identification. A cat with neurological or ocular FIP being treated at 6 or 8 mg/kg will be under-dosed because the drug must cross the blood-brain barrier, which requires 10 mg/kg.

What to do: Verify the dose calculation at the start of treatment and recalculate every 2 to 3 weeks. Use our dosage calculator and contact us if you are unsure.

Cause 4: Unreliable Oral Absorption

Oral GS-441524 capsules depend on gastrointestinal absorption. In a cat with active FIP — which frequently causes nausea, vomiting, reduced gastric motility, and intestinal inflammation — oral absorption is variable and unpredictable. A cat that vomits after taking an oral capsule has not absorbed the dose.

Oral GS-441524 is appropriate for cats that are clinically stable, eating well, and have normal gastrointestinal function — typically after 2 to 4 weeks of injectable treatment has established a clinical response. It is not appropriate as the starting form for cats with active nausea, vomiting, or gastrointestinal involvement, or for neurological or ocular FIP at any stage.

What to do: If a cat on oral GS-441524 is vomiting after doses or not responding as expected, switch to injectable immediately. Read our injectable vs oral guide.

Cause 5: Misdiagnosis

FIP diagnosis without the full diagnostic workup is frequently incorrect. Several conditions produce clinical signs and blood work patterns that overlap significantly with FIP — lymphoma, toxoplasmosis, bacterial peritonitis, chronic kidney disease, FeLV-associated disease, and inflammatory bowel disease.

A cat that does not respond to GS-441524 at the correct dose after 7 to 14 days of treatment should have the diagnosis reassessed before the dose is escalated further. GS-441524 is specific to coronavirus RNA polymerase — it will not produce a clinical response in a cat that has lymphoma or toxoplasmosis.

What to do: Ensure the diagnosis was made with the full workup — A:G ratio, Rivalta test, fluid cytology, FCoV PCR, and ultrasound. Read our complete FIP diagnostic guide and our guide on conditions commonly confused with FIP.

Cause 6: Concurrent Illness Complicating Response

Cats with concurrent FeLV, FIV, severe chronic kidney disease, or other significant systemic illness may respond more slowly or less completely to GS-441524 treatment. FeLV in particular is associated with reduced treatment response in FIP, because FeLV causes immunosuppression that impairs the immune clearance process that GS-441524 depends on.

What to do: Screen for FeLV and FIV at diagnosis if not already done. Monitor blood work more frequently than the standard 30/60/84-day schedule in cats with significant concurrent illness. Read our complete blood work guide. Contact us if your cat has concurrent conditions.

Cause 7: Relying on Supportive Care Instead of Antiviral Treatment

Steroids, immune modulators, and other supportive medications can reduce inflammation and improve a cat’s comfort during FIP — but they cannot stop viral replication. Supportive care — anti-nausea medication, appetite stimulants, subcutaneous fluids, Vitamin B12, liver support — is used alongside GS-441524, not instead of it.

What to do: Use supportive care as an adjunct to GS-441524, not a substitute. If your cat is on steroids without GS-441524, discuss starting antiviral treatment with your vet immediately. Read our complete supportive care guide.

Cause 8: Drug Resistance (Rare)

Under sustained sub-therapeutic drug pressure — most commonly from consistent under-dosing over a prolonged period — the FIP virus can develop mutations that reduce its sensitivity to GS-441524. This is rare when the correct dose is used consistently from the start, but has been documented in cats that received prolonged sub-therapeutic treatment.

What to do: If drug resistance is suspected, this requires specialist veterinary assessment. Contact us or your vet for a full reassessment of the diagnosis, dose, and delivery method before concluding that resistance is the cause.

The Correct Response to Treatment Failure: A Decision Framework

  1. Verify the dose. Recalculate using the cat’s current weight and the correct mg/kg for the confirmed FIP form. Use our dosage calculator.
  2. Verify delivery. Is the cat on oral capsules and vomiting? Switch to injectable. Is the injectable being administered correctly subcutaneously?
  3. Verify the diagnosis. Was the full diagnostic workup performed — A:G ratio, Rivalta test, fluid cytology, FCoV PCR? Could this be a condition other than FIP?
  4. Check for concurrent illness. Has the cat been screened for FeLV, FIV, and other conditions that could complicate response?
  5. Contact your vet or contact FIP Cure Plus. Do not make dose adjustments without guidance. Present the treatment log, current weight, dose calculation, and clinical observations.

Frequently Asked Questions

My cat has been on GS-441524 for 10 days with no improvement. Should I stop treatment?
No. Contact us or your vet immediately to review the dose, delivery method, and diagnosis. Do not stop treatment without veterinary guidance. The most common causes of no early response are under-dosing and unreliable oral absorption — both of which are correctable without stopping treatment.

My cat improved initially but is now getting worse at week 4. What does this mean?
Deterioration after initial improvement most commonly indicates under-dosing that was insufficient to fully suppress replication, or a dose that has not been recalculated as the cat gained weight. Contact your vet for a dose review and blood work. Read our FIP relapse guide.

Can I increase the dose myself if I think it is not working?
No. Dose adjustments should be made in consultation with your vet or FIP Cure Plus. Present the cat’s current weight, the dose calculation, and the clinical observations.

My cat completed the full 84-day protocol but relapsed during the observation period. What now?
Retreatment with GS-441524 at a higher dose than the original protocol is effective in most relapse cases when started promptly. Contact us immediately for blood work to confirm relapse and begin retreatment. Read our complete FIP relapse guide.

How do I know if my cat’s GS-441524 is genuine and at the correct concentration?
Purchase GS-441524 only from suppliers who provide documented product testing and concentration verification. FIP Cure Plus GS-441524 is laboratory-tested for purity and concentration. View our safety and efficacy page for full documentation.


GS-441524 treatment failure is almost never random. It is almost always traceable to a specific, identifiable cause — and most of those causes are either preventable or correctable. Start at the correct dose, use injectable GS-441524, recalculate the dose as weight changes, complete all 84 days, and keep every blood work appointment. That is how you stay in the 92%.

The FIP Cure Plus team is available in English and Arabic at info@fipcureplus.com.

View the FIP Cure Plus GS-441524 20 mg/ml injectable →

View the FIP Cure Plus GS-441524 30 mg/ml injectable →

View the FIP Cure Plus GS-441524 oral capsules →

FIP Cure Plus — transparent, evidence-based GS-441524 treatment for cats across the Gulf.

Back to blog